TransUnion (TRU) director Charlotte Yarkoni granted 836 restricted shares

Q: What insider transaction did TransUnion (TRU) report for Charlotte Yarkoni?

On January 5, 2026, TransUnion director Charlotte Yarkoni received a grant of 836 shares of common stock as a restricted stock award at $0 per share .

Q: Why did Charlotte Yarkoni receive 836 TransUnion (TRU) shares?

The 836-share grant represents restricted stock awarded in connection with Ms. Yarkoni's appointment to the Board of Directors of TransUnion.

Q: When do Charlotte Yarkoni’s restricted TransUnion (TRU) shares vest?

The filing states that Ms. Yarkoni's 836 restricted shares will vest on May 7, 2026 , at which point the vesting conditions are satisfied.

Q: How many TransUnion (TRU) shares does Charlotte Yarkoni own after this grant?

After the reported transaction, Ms. Yarkoni beneficially owns 836 shares of TransUnion common stock, held as direct ownership .

Q: Was Charlotte Yarkoni’s TransUnion (TRU) stock grant part of a 10b5-1 plan?

The section for indicating a Rule 10b5-1(c) trading plan is present, but there is no box marked to show that this grant was made under such a plan.

Q: Is the reported TransUnion (TRU) transaction a purchase or a grant?

The transaction is coded as “A” for acquisition and described as a grant of restricted stock to Ms. Yarkoni, rather than an open-market purchase.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

TransUnion director Charlotte Yarkoni reported a new equity award. On January 5, 2026, she received a grant of 836 shares of TransUnion common stock at a price of $0 per share. This reflects a restricted stock award tied to her service on the Board of Directors.

The 836 restricted shares will vest on May 7, 2026, meaning they become fully owned by her on that date if the vesting conditions are met. Following this grant, she beneficially owns 836 TransUnion shares directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Yarkoni Charlotte

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	836	$0.00	--

Holdings After Transaction: Common Stock — 836 shares (Direct)

Footnotes (1)

[object Object]

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/07/2026 - 05:44 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Yarkoni Charlotte

(Last)

(First)

(Middle)

C/O TRANSUNION

555 WEST ADAMS STREET

(Street)

CHICAGO

60661

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
TransUnion [ TRU ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/05/2026		A⁽¹⁾		836	A	$0	836	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents a grant of restricted stock in connection with Ms. Yarkoni's appointment to the Board of Directors, which will vest on May 7, 2026.

Remarks:

	/s/ Rachel Mantz, by power of attorney	01/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did TransUnion (TRU) report for Charlotte Yarkoni?

On January 5, 2026, TransUnion director Charlotte Yarkoni received a grant of 836 shares of common stock as a restricted stock award at $0 per share.

Why did Charlotte Yarkoni receive 836 TransUnion (TRU) shares?

The 836-share grant represents restricted stock awarded in connection with Ms. Yarkoni's appointment to the Board of Directors of TransUnion.

When do Charlotte Yarkoni’s restricted TransUnion (TRU) shares vest?

The filing states that Ms. Yarkoni's 836 restricted shares will vest on May 7, 2026, at which point the vesting conditions are satisfied.

How many TransUnion (TRU) shares does Charlotte Yarkoni own after this grant?

After the reported transaction, Ms. Yarkoni beneficially owns 836 shares of TransUnion common stock, held as direct ownership.

Was Charlotte Yarkoni’s TransUnion (TRU) stock grant part of a 10b5-1 plan?

The section for indicating a Rule 10b5-1(c) trading plan is present, but there is no box marked to show that this grant was made under such a plan.

Is the reported TransUnion (TRU) transaction a purchase or a grant?

The transaction is coded as “A” for acquisition and described as a grant of restricted stock to Ms. Yarkoni, rather than an open-market purchase.